Documents | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Documents

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Document Type

  • Publication (12)
  • DEA Administrator Remarks (1)
  • Testimony (1)

Publication Type

  • Intelligence (6)
  • Forensics: Quality Management System Documents (3)
  • Forensics (2)
  • DEA Administrator (1)
  • Drug Prevention (1)

Drug Name

  • Narcóticos (opioides) (23)
  • Fentanyl (11)
  • Methamphetamine (10)
  • Drugs of Concern (7)
  • Xylazine (5)
  • Marijuana (4)
  • Cocaine (2)
  • Designer Drugs (1)
  • Hallucinogen (1)
  • Ketamine (1)
  • Spice/K2, Synthetic Marijuana (1)
  • Steroids (1)
  • Heroin (7)
  • Cannabis (5)
  • Synthetic Opioids (2)

Topic

  • Forensics: Quality Management System Documents (3)
  • Forensic Sciences (2)
  • Family (1)
  • Self Help/Personal Growth (1)
Clear All Results
DOCUMENT

CY 2024 Heroin Report

Septiembre 22, 2025
Publication
The United States Drug Enforcement Administration (DEA) Office of Forensic Sciences laboratory system is comprised of eight regional laboratories distributed across the United States. Heroin seizures ranging in weight from residue to multiple kilograms are routinely analyzed in these laboratories. The analytical protocol typically requires the identification of heroin, other...
Septiembre 22, 2025
DOCUMENT

CY 2023 Annual Heroin Report

Septiembre 22, 2025
Publication
The United States Drug Enforcement Administration (DEA) Office of Forensic Sciences laboratory system is comprised of eight regional laboratories distributed across the United States. Heroin seizures ranging in weight from residue to multiple kilograms are routinely analyzed in these laboratories. The analytical protocol typically requires the identification of heroin, other...
Septiembre 22, 2025
DOCUMENT

Standard Operating Procedure for the Analysis of Suspected Cannabis Plant Material

Agosto 02, 2023
Publication
This document is an internal Drug Enforcement Administration quality system document. The document is updated periodically and is current as of August 1, 2022 and is provided for informational purposes only. Any sensitive, privileged or otherwise protected information has been redacted, to include the redaction of some document in their...
Agosto 02, 2023
DOCUMENT

Standard Operating Procedure for the Analysis of Cannabis Liquids and Extracts

Agosto 02, 2023
Publication
This document is an internal Drug Enforcement Administration quality system document. The document is updated periodically and is current as of August 15, 2022 and is provided for informational purposes only. Any sensitive, privileged or otherwise protected information has been redacted, to include the redaction of some document in their...
Agosto 02, 2023
DOCUMENT

Standard Operating Procedure for the Analysis of Suspected Natural and Synthetic Opioids

Agosto 02, 2023
Publication
This document is an internal Drug Enforcement Administration quality system document. The document is updated periodically and is current as of February 1 , 2023 and is provided for informational purposes only. Any sensitive, privileged or otherwise protected information has been redacted, to include the redaction of some document in...
Agosto 02, 2023
DOCUMENT

DOJ and DEA Announce Charges against Chapitos

Abril 14, 2023
DEA Administrator Remarks
“Today’s indictments send a clear message to the Chapitos, the Sinaloa Cartel, and criminal drug networks around the world that the DEA will stop at nothing to protect the national security of the United States and the safety and health of the American people,” said DEA Administrator Anne Milgram. “The...
Abril 14, 2023
DOCUMENT

Illicit Opioid Availability in Pennsylvania 2020

Diciembre 30, 2020
Publication
The increasing availability of illicit opioids is the most significant drug threat in Pennsylvania. The Philadelphia Field Division (PFD) monitors this threat closely, periodically reviewing multiple data indicators, in conjunction with investigative information, to continually assess the threat, then share analytical findings with stakeholders in federal, state, and municipal governments.
Diciembre 30, 2020
DOCUMENT

The 2018 Heroin Signature Program

Septiembre 03, 2020
Publication
The Drug Enforcement Administration (DEA) Heroin Signature Program (HSP) analyzes hundreds of wholesale-level heroin samples each year to identify the geographic area—Mexico, South America (SA), Southwest Asia (SWA), or Southeast Asia (SEA)—where the samples were manufactured.
Septiembre 03, 2020
DOCUMENT

The 2017 Heroin Signature Program Publication

Agosto 11, 2020
Publication
The HSP (Heroin Signature Program) is one essential component of the DEA’s Intelligence Program to identify trends in heroin trafficking and distribution in the United States. The objective of the program is to identify and quantify the chemical components of heroin seized at U.S. ports of entry (POE), all non-POE...
Agosto 11, 2020
DOCUMENT

Statement of the Drug Enforcement Administration before the House Committee on Energy and Commerce-Subcommittee on Health for a Hearing Entitled: Cannabis Policy-For The New Decade

Enero 15, 2020
Testimony
Matthew J. Strait, Senior Policy Advisor, Diversion Control Division-DEA; Before the House Energy and Commerce Committee-Subcommittee on Health, for a Hearing Entitled: Cannabis Policy-For the New Decade
Enero 15, 2020
Showing 1 - 10 of 14 results

Paginación

  • Current page 1
  • Página 2
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster